Nanjing Mingde New Drug Research describes new CYP11B2 inhibitors for hypertension
Dec. 10, 2024
Nanjing Mingde New Drug Research Co. Ltd. has identified cytochrome P450 11B2, mitochondrial (CYP11B2; aldosterone synthase; ALDOS) inhibitors reported to be useful for the treatment of hypertension.